Effects of Dietary Intake of Soy Protein and Isoflavones on Cardiovascular Disease Risk Factors in High Risk, Middle-Aged Men in Scotland

Journal of the American College of Nutrition

Volumn 23, Issue 1, 2004, Pages 85-91

  Sagara, Miki ^a   Kanda, Tomo ^b   Njelekera, Marina ^b   Teramoto, Takanori ^c   Armitage, Lesley ^f   Birt, Nina ^e   Birt, Christopher ^e   Yamori, Yukio ^d  

^a RESEARCH INSTITUTE FOR PRODUCTION DEVELOPMENT   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c WHO Collaborating Center for Research on Primary Prevention of Cardiovascular Diseases   (Japan)

^d International Center for Research on Primary Prevention of Cardiovascular Diseases   (Japan)

^e Wigan and Bolton Health Authority   (United Kingdom)

^f UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Blood pressure; Cholesterol; Isoflavone; Men; Middle aged; Soy protein

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOFLAVONE DERIVATIVE; OLIVE OIL; PLACEBO; SOYBEAN PROTEIN;

ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; UNITED KINGDOM;

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; DOUBLE-BLIND METHOD; HUMANS; ISOFLAVONES; MALE; MIDDLE AGED; PLACEBOS; RISK FACTORS; SCOTLAND; SOYBEAN PROTEINS; TRIGLYCERIDES;

GLYCINE MAX;

EID: 1042298095     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2004.10719347     Document Type: Article

References (42)

1. Beaglehole R: International trends in coronary heart disease mortality, morbidity, and risk factors. Epidemiol Rev 12:1-15, 1990.
2. Anderson JW, Johnstone BM, Cook-Newell ME: Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333:276-282, 1995.
3. Potter SM: Soy protein and cardiovascular diseases: the impact of bioactive components in soy. Nutr Rev 56:231-235, 1998.
4. Yamori Y, on behalf of WHO-CARDIAC Study group: Soy beans for health in the world-Lessons from Okinawan diets and healthy longevity by WHO-CARDIAC and immigrants studies. The Third International Soybean Processing and Utilization Conference 2000: Dawn of the Innovative Era for Soybeans. Proceedings:195-198, 2000.
5. Jenkins DJ, Kendall CW, Jackson CJ, Connelly PW, Parker T, Faulkner D, Vidgen E, Cunnane SC, Leiter LA, Josse RG: Effects of high-and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr 76:365-372, 2002.
6. Rivas M, Garay RP, Escanero JF, Cia Jr P, Cia P, Alda JO: Soy milk lowers blood pressure in men and women with mild to moderate essential hypertension. J Nutr 132:1900-1902, 2002.
7. Washburn S, Burke GL, Morgan T, Anthony M: Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 6:7-13, 1999.
8. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A: Myocardial infarction and coronary deaths in the WHO MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90:583-612, 1994
9. Whichelow MJ, Erzinclioglu SW, Cox BD: Some regional variations in dietary patterns in a random sample of British adults. Eur J Clin Nutr 45:253-262, 1991.
10. Bolton-Smith C, Woodward M, Tunstall-Pedoe H: The Scottish Heart Health Study. Dietary intake by food frequency questionnaire and odds ratios for coronary heart disease risk. I. The macronutrients. Eur J Clin Nutr 46:75-84, 1992.
11. Todd S, Woodward M, Bolton-Smith C, Tunstall-Pedoe H: An investigation of the relationship between antioxidant vitamin intake and coronary heart disease in men and women using discriminant analysis. J Clin Epidemiol 48:297-305, 1995.
12. Kanda T, Sagara M, Hirao S, Lin LJ, Negishi H, Akazawa T, Yoshida H, Honda K, Ikeda K, Yamori Y: Soy bean diets decrease cardiovascular risk factors in Japanese immigrants living in Hawaii. The Third International Soybean Processing and Utilization Conference. Dawn of the Innovative Era for Soybeans. Proceedings: 199-200, 2000.
13. WHO Collaborating Center on Primary Prevention of Cardiovascular Diseases, and Cardiovascular Disease Unit, WHO: "Cardiovascular Disease and Alimentary Comparison (CARDIAC) Study Protocol and Manual of Operations." WHO Collaborating Center on Primary Prevention of Cardiovascular Diseases and WHO, Shimane/Geneva, 1986.
14. Yamori Y, Nara Y, Kihara M, Mano M, Horie R: Simple method for sampling consecutive 24-hour urine for epidemiological and clinical studies. Clin Exp Hypertens A 6:1161-1167, 1984.
15. Uesugi T, Fukui Y, Yamori Y: Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal Japanese women: a four-week study. J Am Coll Nutr 21:97-102, 2002.
16. Liu L, Mizushima S, Ikeda K, Hattori H, Miura A, Gao M, Nara Y, Yamori Y: Comparative studies of diet-related factors and blood pressure among Chinese and Japanese: results from the China-Japan Cooperative Research of the WHO-CARDIAC Study. Hypertens Res 23:413-420, 2000.
17. Washburn S, Burke GL, Morgan T, Anthony M: Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 6:7-13, 1999.
18. Teede HJ, Dalais FS, Kotsopoulos D, Liang YL, Davis S, McGrath BP: Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. J Clin Endocrinol Metab 86:3053-3060, 2001.
19. Rivas M, Garay RP, Escanero JF, Cia Jr P, Cia P, Alda JO: Soy milk lowers blood pressure in men and women with mild to moderate essential hypertension. J Nutr 132:1900-1902, 2002.
20. Davis SR, Dalais FS, Simpson ER, Murkies AL: Phytoestrogens in health and disease. Recent Prog Horm Res 54:185-210, 1999.
21. Scuteri A, Bos AJ, Brant LJ, Talbot L, Lakatta EG, Fleg JL: Hormone replacement therapy and longitudinal changes in blood pressure in postmenopausal women. Ann Intern Med 135:229-238, 2001
22. Isles CG, Hole DJ, Hawthorne VM, Lever AF: Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey: comparison with men. Lancet 339(8795):702-706, 1992.
23. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M: Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators. N Engl J Med 328:1069-1075, 1993.
24. Harrison-Bernard LM, Raij L: Postmenopausal hypertension. Curr Hypertens Rep 2:202-207, 2000.
25. Yamori Y, Teramoto T, Noguchi T, Sekine Y, Nara Y, Ikeda K: Soy isoflavone, daidzein, attenuates postovariectomized blood pressure elevation by accelerationg nitric oxide production [Abstract]. J Nutr 130:739S, 2000.
26. Xu J-W, Ikeda K, Teramoto T, Yamori Y: Influence of isoflavones on endothelin-1 and eNOS in cultured aortic endothelial cells from stroke-prone spontaneously hypertensive rats. J Hypertens 20(Suppl 4):S333, 2002.
27. Gardner CD, Newell KA, Cherin R, Haskell WL: The effect of soy protein with or without isoflavones relative to milk protein on plasma lipids in hypercholesterolemic postmenopausal women. Am J Clin Nutr 73:728-735, 2001.
28. Crouse 3rd JR, Morgan T, Terry JG, Ellis J, Vitolins M, Burke GL: A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch Intern Med 159:2070-2076, 1999.
29. Baum JA, Teng H, Erdman Jr JW, Weigel RM, Klein BP, Persky VW, Freels S, Surya P, Bakhit RM, Ramos E, Shay NF, Potter SM: Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. Am J Clin Nutr 68:545-551, 1998.
30. Sanders TA, Dean TS, Grainger D, Miller GJ, Wiseman H: Moderate intakes of intact soy protein rich in isoflavones compared with ethanol-extracted soy protein increase HDL but do not influence transforming growth factor beta (1) concentrations and hemostatic risk factors for coronary heart disease in healthy subjects. Am J Clin Nutr 76:373-377, 2002.
31. Ashton EL, Dalais FS, Ball MJ: Effect of meat replacement by tofu on CHD risk factors including copper induced LDL oxidation. J Am Coll Nutr 19:761-767, 2000.
32. Kris-Etherton PM, Pearson TA, Wan Y, Hargrove RL, Moriarty K, Fishell V, Etherton TD: High-monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations. Am J Clin Nutr 70:1009-1015, 1999.
33. Larsen LF, Jespersen J, Marckmann P: Are olive oil diets antithrombotic? Diets enriched with olive, rapeseed, or sunflower oil affect postprandial factor VII differently. Am J Clin Nutr 70:976-982, 1999.
34. Zambon A, Sartore G, Passera D, Francini-Pesenti F, Bassi A, Basso C, Zambon S, Manzato E, Crepaldi G: Effects of hypocaloric dietary treatment enriched in oleic acid on LDL and HDL subclass distribution in mildly obese women. J Intern Med 246: 191-201, 1999.
35. Mattson FH, Grundy SM: Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J Lipid Res 26:194-202, 1985.
36. Mensink RP, Katan MB: Effect of a diet enriched with monounsaturated or polyunsaturated fatty acids on levels of low-density and high-density lipoprotein cholesterol in healthy women and men. N Engl J Med 321:436-441, 1989.
37. Berry EM, Eisenberg S, Haratz D, Friedlander Y, Norman Y, Kaufmann NA, Stein Y: Effects of diets rich in monounsaturated fatty acids on plasma lipoproteins-The Jerusalem Nutrition Study: High MUFAs vs High PUFAs. Am J Clin Nutr 53:899-907, 1991.
38. G Baggio, A Pagnan, M Muraca, S Martini, A Opportuno, A Bonanome, GB Ambrosio, S Ferrari, P Guarini, and D Piccolo: Olive-oil-enriched diet: effect on serum lipoprotein levels and biliary cholesterol saturation. Am J Clin Nutr 47:960-964, 1988.
39. Food labeling: health claims; soy protein and coronary heart disease. Food and Drug Administration, HHS. Final rule. Fed Regist 26, 64 (206):57700-57733, 1999.
40. Teixeira SR, Potter SM, Weigel R, Hannum S, Erdman JW Jr, Hasler CM: Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men. Am J Clin Nutr 71:1077-1084, 2000.
41. Kondo K, Suzuki Y, Ikeda Y, Umemura K: Genistein, an isoflavone included in soy, inhibits thrombotic vessel occlusion in the mouse femoral artery and in vitro platelet aggregation. Eur J Pharmacol 455:53-57, 2002
42. Williams JK, Clarkson TB: Dietary soy isoflavones inhibit in-vivo constrictor responses of coronary arteries to collagen-induced platelet activation. Coron Artery Dis 9:759-764, 1998